Yossi Maimon
2006 - Protalix BioTherapeutics
In 2006, Yossi Maimon earned a total compensation of $164.5K as Chief Financial Officer at Protalix BioTherapeutics.
Compensation breakdown
| Bonus | $31,953 |
|---|---|
| Option Awards | $96,712 |
| Salary | $27,746 |
| Other | $8,077 |
| Total | $164,488 |
Maimon received $96.7K in option awards, accounting for 59% of the total pay in 2006.
Maimon also received $32K in bonus, $27.7K in salary and $8.1K in other compensation.
Rankings
In 2006, Yossi Maimon's compensation ranked 6,635th out of 7,022 executives tracked by ExecPay. In other words, Maimon earned more than 5.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,635 out of 7,022 | 6th |
Division Manufacturing | 2,302 out of 2,413 | 5th |
Major group Chemicals And Allied Products | 637 out of 673 | 5th |
Industry group Drugs | 484 out of 518 | 7th |
Industry Biological Products, Except Diagnostic Substances | 108 out of 112 | 4th |
Source: SEC filing on October 3, 2008.
Maimon's colleagues
We found three more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2006.